Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction

被引：18

作者：

Tromp, J. ^{[1
]}

Steggink, L. C. ^{[2
]}

Van Veldhuisen, D. J. ^{[1
]}

Gietema, J. A. ^{[2
]}

van der Meer, P. ^{[1
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands

[2] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / 04期

关键词：

ANTHRACYCLINE-INDUCED CARDIOMYOPATHY; CHEMOTHERAPY-INDUCED CARDIOTOXICITY; CELL-DERIVED CARDIOMYOCYTES; BREAST-CANCER; HEART-FAILURE; RISK-FACTOR; DOXORUBICIN THERAPY; CHILDHOOD-CANCER; FOLLOW-UP; TRASTUZUMAB;

D O I：

10.1002/cpt.614

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Treatment for cancer has improved in the last decades, resulting in a significantly reduced morbidity and mortality. 1-3 Unfortunately, many systemic treatment options are associated with an increased risk of adverse cardiac effects. 4 These adverse cardiac effects have given rise to the field of cardiooncology. This review summarizes recent findings related to the pathophysiology and treatment of drug-induced cardiac dysfunction in cancer treatment and looks ahead at new developments in the field.

引用

页码：481 / 490

页数：10

共 76 条

[1] Protective effects of spironolactone against anthracycline-induced cardiomyopathy [J].

Akpek, Mahmut ;

Ozdogru, Ibrahim ;

Sahin, Omer ;

Inanc, Mevlude ;

Dogan, Ali ;

Yazici, Cevat ;

Berk, Veli ;

Karaca, Halit ;

Kalay, Nihat ;

Oguzhan, Abdurrahman ;

Ergin, Ali .

EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (01) :81-89

[2] Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention [J].

Albini, Adriana ;

Pennesi, Giuseppina ;

Donatelli, Francesco ;

Cammarota, Rosaria ;

De Flora, Silvio ;

Noonan, Douglas M. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (01) :14-25

[3] Cardiovascular toxicity caused by cancer treatment: strategies for early detection [J].

Altena, Renske ;

Perik, Patrick J. ;

van Veldhuisen, Dirk J. ;

de Vries, Elisabeth G. E. ;

Gietema, Jourik A. .

LANCET ONCOLOGY, 2009, 10 (04) :391-399

[4] Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation [J].

Armenian, Saro H. ;

Ding, Yan ;

Mills, George ;

Sun, Canlan ;

Venkataraman, Kalyanasundaram ;

Wong, Florence Lennie ;

Neuhausen, Susan L. ;

Senitzer, David ;

Wang, Shirong ;

Forman, Stephen J. ;

Bhatia, Smita .

BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (02) :205-213

[5] Screening Adult Survivors of Childhood Cancer for Cardiomyopathy: Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging [J].

Armstrong, Gregory T. ;

Plana, Juan Carlos ;

Zhang, Nan ;

Srivastava, Deokumar ;

Green, Daniel M. ;

Ness, Kirsten K. ;

Donovan, F. Daniel ;

Metzger, Monika L. ;

Arevalo, Alejandro ;

Durand, Jean-Bernard ;

Joshi, Vijaya ;

Hudson, Melissa M. ;

Robison, Leslie L. ;

Flamm, Scott D. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (23) :2876-2884

[6] Role of the HER2 [lle655Val] genetic polymorphism in tumorogenesis and in the risk of-trastuzumab-related cardiotoxicity [J].

Beauclair, S. ;

Formento, P. ;

Fischel, J. L. ;

Lescaut, W. ;

Largillier, R. ;

Chamorey, E. ;

Hofman, P. ;

Ferrero, J. M. ;

Pages, G. ;

Milano, G. .

ANNALS OF ONCOLOGY, 2007, 18 (08) :1335-1341

[7] State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature review [J].

Berardi, Rossana ;

Caramanti, Miriam ;

Savini, Agnese ;

Chiorrini, Silvia ;

Pierantoni, Chiara ;

Onofri, Azzurra ;

Ballatore, Zelmira ;

De Lisa, Mariagrazia ;

Mazzanti, Paola ;

Cascinu, Stefano .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (01) :75-86

[8] Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes-A Report From the Children's Oncology Group [J].

Blanco, Javier G. ;

Sun, Can-Lan ;

Landier, Wendy ;

Chen, Lu ;

Esparza-Duran, Diego ;

Leisenring, Wendy ;

Mays, Allison ;

Friedman, Debra L. ;

Ginsberg, Jill P. ;

Hudson, Melissa M. ;

Neglia, Joseph P. ;

Oeffinger, Kevin C. ;

Ritchey, A. Kim ;

Villaluna, Doojduen ;

Relling, Mary V. ;

Bhatia, Smita .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) :1415-1421

[9] Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial [J].

Boekhout, Annelies H. ;

Gietema, Jourik A. ;

Kerklaan, Bojana Milojkovic ;

van werkhoven, Erik D. ;

Altena, Renske ;

Honkoop, Aafke ;

Los, Maartje ;

Smit, Willem M. ;

Nieboer, Peter ;

Smorenburg, Carolien H. ;

Mandigers, Caroline M. P. W. ;

van der Wouw, Agnes J. ;

Kessels, Lonneke ;

van der Velden, Annette W. G. ;

Ottevanger, Petronella B. ;

Smilde, Tineke ;

de Boer, Jaap ;

van Veldhuisen, Dirk J. ;

Kema, Ido P. ;

de Vries, Elisabeth G. E. ;

Schellens, Jan H. M. .

JAMA ONCOLOGY, 2016, 2 (08) :1030-1037

[10] Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population [J].

Boerman, L. M. ;

Berendsen, A. J. ;

van der Meer, P. ;

Maduro, J. H. ;

Berger, M. Y. ;

de Bock, G. H. .

SUPPORTIVE CARE IN CANCER, 2014, 22 (07) :1949-1958

← 1 2 3 4 5 6 7 8 →